NCT01844193

Brief Summary

This study will examine the effects, if any, of using muscle stimulation on the quadriceps following a total knee replacement. Secondary objectives will be to evaluate and compare pain levels, qualitative outcomes, and the impact of NMES on pain medication requests between groups. It is possible that strengthening the quadriceps muscles and improving their activation will reduce postoperative pain and help patients return to activities sooner than with standard therapy alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

January 11, 2013

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 1, 2013

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

April 12, 2021

Completed
Last Updated

April 12, 2021

Status Verified

April 1, 2021

Enrollment Period

4 years

First QC Date

January 11, 2013

Results QC Date

June 8, 2020

Last Update Submit

April 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Quadriceps Force

    Change in quadriceps force is the difference between average quadriceps force measurements (in Newtons) obtained at the 1-year postoperative follow-up minus the average quadriceps force measurement at baseline. Averages are stratified by study arm. Negative values indicate a reduction in quadriceps force from baseline measurement to 1-year.

    Baseline and 1-year Follow-up

Secondary Outcomes (1)

  • Change in VAS Pain Scores

    Baseline and 1-year Follow-up

Study Arms (2)

Standard Therapy

NO INTERVENTION

This arm of the study will follow the standard therapy course after total knee arthroplasty.

Standard Therapy + NMES

EXPERIMENTAL

This arm will follow the standard course of therapy but also incorporate daily neuromuscular electrical stimulation into the daily therapy regimen after total knee arthroplasty through use of the Compex Rehab device.

Device: Compex Rehab

Interventions

Participants in this arm will use a Compex® Rehab unit for neuromuscular electrical stimulation starting with postoperative at-home day 1 and continue using the unit twice a day, every day, until a 10-week follow-up is reached. The unit produces a 380 microsecond biphasic curve and utilizes a four phase process for the treatment ("Warm-up", "Work", "Relaxation", and "Recovery") for a total treatment time of 20 minutes and 5 seconds per session. All frequencies are delivered at the maximum subjective tolerable intensity. Participants will control this intensity and be asked to select a level that is tolerable although mildly uncomfortable; they will be instructed to increase this intensity as tolerated.

Standard Therapy + NMES

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is a candidate for unilateral primary total knee arthroplasty and has a primary diagnosis of osteoarthritis.
  • Patient is a male or non-pregnant female age 18 and older at time of surgery.
  • Patient has signed an Institutional review board (IRB)-approved, study-specific informed consent form.
  • Patient is willing and able to comply with the postoperative scheduled clinical evaluations and rehabilitation.

You may not qualify if:

  • Patient has active infection within the affected knee joint.
  • Patient requires revision surgery of a previously implanted total knee arthroplasty.
  • Patient is morbidly obese, defined as having a body mass index (BMI) greater than or equal to 36.
  • Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the intervention.
  • Patient has been diagnosed with a systemic disease or current life threatening illness and is not able to carry on normal activities of daily life (e.g. Paget's disease, renal osteodystrophy, etc.).
  • Patient has a history of cardiac issues including myocardial infarction and/or has a pacemaker.
  • Patient is immunologically suppressed or receiving chronic steroids in excess of 5mg per day.
  • Patient has a recent history of substance dependency that may result in deviations from the evaluation schedule.
  • Patient is a prisoner.
  • Patient has indication for contralateral total knee arthroplasty within the evaluation window.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OrthoIndy

Greenwood, Indiana, 46143, United States

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Results Point of Contact

Title
Dr. Frank Kolisek
Organization
OrthoIndy

Study Officials

  • Frank R Kolisek, MD

    OrthoIndy South

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2013

First Posted

May 1, 2013

Study Start

January 1, 2013

Primary Completion

December 31, 2016

Study Completion

December 31, 2016

Last Updated

April 12, 2021

Results First Posted

April 12, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations